Advanced search
Publication Cover
Therapeutics and Clinical Risk Management Volume 3, 2007 - Issue 2
Submit an article Journal homepage
385
Views
4
CrossRef citations to date
0
Altmetric
Reviews

Sunitinib: a novel tyrosine kinase inhibitor. A brief review of its therapeutic potential in the treatment of renal carcinoma and gastrointestinal stromal tumors (GIST)

Christophe Le TourneauDepartment of Medical OncologyHôpital Beaujon, Clichy, FranceCorrespondence[email protected]
,
Eric RaymondDepartment of Medical OncologyHôpital Beaujon, Clichy, France
&
Sandrine FaivreDepartment of Medical OncologyHôpital Beaujon, Clichy, France
Pages 341-348 | Published online: 28 Dec 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.